C-terminal region of GADD34 regulates eIF2α dephosphorylation and cell proliferation in CHO-K1 cells

Cell Stress & Chaperones
Ryo OtsukaHiroshi Sakaue

Abstract

GADD34 is a member of a growth arrest and DNA damage (GADD)-inducible gene family. Here, we established a novel Chinese hamster ovary (CHO)-K1-derived cell line, CHO-K1-G34M, which carries a nonsense mutation (termed the Q525X mutation) in the GADD34 gene. The Q525X mutant protein lacks the C-terminal 66 amino acids required for GADD34 to bind to and activate protein phosphatase 1 (PP1). We investigated the effects of GADD34 with or without the Q525X mutation on the phosphorylation status of PP1 target proteins, including the α subunit of eukaryotic initiation factor 2 (eIF2α) and glycogen synthase kinase 3β (GSK3β). CHO-K1-G34M cells had higher levels of eIF2α phosphorylation compared to the control CHO-K1-normal cells both in the presence and absence of endoplasmic reticulum stress. Overexpression of the wild-type GADD34 protein in CHO-K1-normal cells largely reduced eIF2α phosphorylation, while overexpression of the Q525X mutant did not produce similar reductions. Meanwhile, neither wild type nor Q525X mutation of GADD34 affected the GSK3β phosphorylation status. GADD34 also did not affect the canonical Wnt signaling pathway downstream of GSK3β. Cell proliferation rates were higher, while expression levels of the cyclin-depe...Continue Reading

References

Oct 1, 1989·Molecular and Cellular Biology·A J FornaceN J Holbrook
May 23, 1997·The Journal of Biological Chemistry·M C HollanderA J Fornace
Aug 19, 1997·Proceedings of the National Academy of Sciences of the United States of America·Z Z SuP B Fisher
Mar 6, 1999·Biochemical and Biophysical Research Communications·T HasegawaK Isobe
May 13, 1999·Proceedings of the National Academy of Sciences of the United States of America·M ShtutmanA Ben-Ze'ev
Jul 27, 2000·The Journal of Biological Chemistry·V W DingF McCormick
May 2, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Koji KojimaCharles A Vacanti
Jun 19, 2003·Oncogene·M Christine HollanderAlbert J Fornace
Nov 25, 2003·Journal of Cellular Biochemistry·Ayako YagiKen-Ichi Isobe
Jun 20, 2006·Trends in Molecular Medicine·Holly A Kuzmiak, Lynne E Maquat
May 5, 2007·Diabetes Research and Clinical Practice·Jongsoon Lee, Myung-Sunny Kim
Feb 13, 2008·Biochemical and Biophysical Research Communications·Nagakatsu HaradaYutaka Nakaya
Jul 16, 2008·Trends in Biochemical Sciences·Nicholas J McGlincy, Christopher W J Smith
Feb 5, 2009·Nature Structural & Molecular Biology·Saverio Brogna, Jikai Wen
Mar 4, 2010·Molecular Endocrinology·Scott M EbertChristopher M Adams
Apr 20, 2010·Trends in Biochemical Sciences·Mathieu BollenMonique Beullens
Jul 24, 2010·Molecular and Cellular Biochemistry·Félix HernándezNieves Villanueva
Jan 31, 2012·Biochemical and Biophysical Research Communications·Tadahiko NakagawaYutaka Nakaya
Dec 2, 2014·Pharmacology & Therapeutics·Eleonore BeurelRichard S Jope

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.